Switch theme
Sign up to access all valuation multiples
Dr Miele Cosmed Group SA is engaged in manufacturing cosmetics and household chemicals for national and international retailers, fulfils consumer needs in the sector of personal care, hygiene and cleanliness. The company's brands include Apart, Biophen, Mole, Bobini, Sofin and Izo.
1986
723
LTM Revenue n/a
LTM EBITDA n/a
$107M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Dr. Miele Cosmed Group has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Dr. Miele Cosmed Group achieved revenue of $114M and an EBITDA of $11.3M.
Dr. Miele Cosmed Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Dr. Miele Cosmed Group valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $102M | $114M | XXX | XXX | XXX |
| Gross Profit | $34.3M | $32.2M | XXX | XXX | XXX |
| Gross Margin | 34% | 28% | XXX | XXX | XXX |
| EBITDA | $3.3M | $11.3M | XXX | XXX | XXX |
| EBITDA Margin | 3% | 10% | XXX | XXX | XXX |
| Net Profit | $3.0M | -$0.6M | XXX | XXX | XXX |
| Net Margin | 3% | -1% | XXX | XXX | XXX |
| Net Debt | $9.9M | $11.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Dr. Miele Cosmed Group's stock price is PLN 4 (or $1).
Dr. Miele Cosmed Group has current market cap of PLN 366M (or $93.9M), and EV of PLN 418M (or $107M).
See Dr. Miele Cosmed Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $107M | $93.9M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Dr. Miele Cosmed Group has market cap of $93.9M and EV of $107M.
Dr. Miele Cosmed Group's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Dr. Miele Cosmed Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Dr. Miele Cosmed Group and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $107M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 9.5x | XXX | XXX | XXX |
| P/E | 16.5x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 19.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpDr. Miele Cosmed Group's NTM/LTM revenue growth is n/a
Dr. Miele Cosmed Group's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $49K for the same period.
Over next 12 months, Dr. Miele Cosmed Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Dr. Miele Cosmed Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Dr. Miele Cosmed Group and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 238% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $49K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 31% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dr. Miele Cosmed Group acquired XXX companies to date.
Last acquisition by Dr. Miele Cosmed Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Dr. Miele Cosmed Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Dr. Miele Cosmed Group founded? | Dr. Miele Cosmed Group was founded in 1986. |
| Where is Dr. Miele Cosmed Group headquartered? | Dr. Miele Cosmed Group is headquartered in Poland. |
| How many employees does Dr. Miele Cosmed Group have? | As of today, Dr. Miele Cosmed Group has 723 employees. |
| Is Dr. Miele Cosmed Group publicy listed? | Yes, Dr. Miele Cosmed Group is a public company listed on WAR. |
| What is the stock symbol of Dr. Miele Cosmed Group? | Dr. Miele Cosmed Group trades under DMG ticker. |
| When did Dr. Miele Cosmed Group go public? | Dr. Miele Cosmed Group went public in 2013. |
| Who are competitors of Dr. Miele Cosmed Group? | Similar companies to Dr. Miele Cosmed Group include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Dr. Miele Cosmed Group? | Dr. Miele Cosmed Group's current market cap is $93.9M |
| What is the current revenue growth of Dr. Miele Cosmed Group? | Dr. Miele Cosmed Group revenue growth between 2023 and 2024 was 12%. |
| Is Dr. Miele Cosmed Group profitable? | Yes, Dr. Miele Cosmed Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
